Kerry Wentworth insider trades: Nuvation Bio (NUVB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kerry reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | NUVB | ↓ Sell | 63,000 | $6.02 | $379K | Direct | Jun 24, 2026 (1d) |
| Apr 6, 2026 | NUVB | ↓ Sell | 200,000 | $4.52 | $904K | Direct | Apr 8, 2026 (2d) |
| Jun 16, 2025 | NUVB | ↑ Buy | 50,000 | $1.79 | $90K | Direct | Jun 18, 2025 (2d) |
| Jul 19, 2021 | FLXN | ↓ Sell | 3,944 | $6.45 | $25K | Direct | Jul 20, 2021 (1d) |
| Jan 5, 2021 | FLXN | ↓ Sell | 6,829 | $11.13 | $76K | Direct | Jan 7, 2021 (2d) |
| Jan 3, 2019 | FLXN | ↓ Sell10b5-1 | 622 | $12.36 | $8K | Direct | Jan 4, 2019 (1d) |
| Feb 26, 2014 | AGEN | ↓ Sell | 5,000 | $5.00 | $25K | Direct | Feb 28, 2014 (2d) |
| Dec 29, 2011 | AGEN | ↓ Sell | 13,988 | $2.05 | $29K | Direct | Dec 29, 2011 (0d) |
| Dec 23, 2011 | AGEN | ↓ Sell | 6,016 | $2.22 | $13K | Direct | Dec 23, 2011 (0d) |
| Oct 26, 2010 | AGEN | ↓ Sell | 4,165 | $0.97 | $4K | Direct | Oct 28, 2010 (2d) |
| Sep 14, 2010 | AGEN | ↓ Sell | 1,453 | $0.91 | $1K | Direct | Sep 14, 2010 (0d) |
| Jul 26, 2010 | AGEN | ↓ Sell | 4,165 | $0.80 | $3K | Direct | Jul 28, 2010 (2d) |
| Apr 26, 2010 | AGEN | ↓ Sell | 4,165 | $1.21 | $5K | Direct | Apr 28, 2010 (2d) |
| Jan 20, 2010 | AGEN | ↓ Sell | 102,316 | $0.85 | $87K | Direct | Jan 21, 2010 (1d) |
| Sep 11, 2009 | AGEN | ↓ Sell | 1,367 | $2.32 | $3K | Direct | Sep 14, 2009 (3d) |
| Jul 16, 2009 | AGEN | ↓ Sell | 33,573 | $1.68 | $56K | Direct | Jul 17, 2009 (1d) |
| Jun 25, 2009 | AGEN | ↓ Sell | 25,000 | $1.97 | $49K | Direct | Jun 29, 2009 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NUVB insiders
Open-market trades in the last 12 months
About Kerry Wentworth's insider trades
Kerry Wentworth is Chief Regulatory Officer at Nuvation Bio (NUVB). Since Jun 25, 2009, Kerry has reported 1 open-market purchase worth $90K and 16 sales worth $1.7M on SEC Form 4. In the last 12 months: 2 sales ($1.3M).
1 sale (0% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (54 filings), shares returned to the company (6 filings), option exercises (3 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.